1001. Tracking maturity of the enabling environment for clinical trials.
作者: Vasee Moorthy.;P J Devereaux.;Carren Sui-Lin Teh.;Indri Rooslamiati.;Ololade D Adeyemi.;Saeed Hamid.;Ana Zanoletty.;Kwasi Nyarko.;Wei Zhang.;Jeremy Farrar.;Ibrahim Abubakar.
来源: Lancet. 2025年406卷10499期113-116页 1013. How Gavi support for RSV immunisation will advance health equity.
作者: Hellen C Barsosio.;Louis J Bont.;Michelle J Groome.;Ruth A Karron.;Leyla Kragten-Tabatabaie.;Shabir A Madhi.;Federico Martinón-Torres.;Clint Pecenka.;Heather J Zar.
来源: Lancet. 2025年406卷10499期127-128页 1018. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
Since its inception in 1974, the Essential Programme on Immunization (EPI) has achieved remarkable success, averting the deaths of an estimated 154 million children worldwide through routine childhood vaccination. However, more recent decades have seen persistent coverage inequities and stagnating progress, which have been further amplified by the COVID-19 pandemic. In 2019, WHO set ambitious goals for improving vaccine coverage globally through the Immunization Agenda 2030 (IA2030). Now halfway through the decade, understanding past and recent coverage trends can help inform and reorient strategies for approaching these aims in the next 5 years.
|